Glycoconjugation as a promising treatment strategy for psoriasis

Published on Jan 1, 2020in Journal of Pharmacology and Experimental Therapeutics3.561
· DOI :10.1124/JPET.119.263657
Sebastian Makuch3
Estimated H-index: 3
(Wrocław Medical University),
Marta Woźniak8
Estimated H-index: 8
(Wrocław Medical University)
+ 3 AuthorsSiddarth Agrawal6
Estimated H-index: 6
(Wrocław Medical University)
Sources
Abstract
Despite the progress in the development of novel treatment modalities, a significant portion of patients with psoriasis remains undertreated relative to the severity of their disease. Recent evidence points to targeting the glucose transporter GLUT1 and sugar metabolism as a novel therapeutic strategy for the treatment of psoriasis and other hyperproliferative skin diseases. In this review, we discuss glycoconjugation, an approach that facilitates the pharmacokinetics of cytotoxic molecules and ensures their preferential influx through glucose transporters. We propose pathways of glycoconjugate synthesis to increase effectiveness, cellular selectivity, and tolerability of widely-used antipsoriatic drugs. The presented approach exploiting the heightened glucose requirement of proliferating keratinocytes bears the potential to revolutionize the management of psoriasis. SIGNIFICANCE STATEMENT Recent findings concerning the fundamental role of enhanced glucose metabolism and GLUT1 overexpression in the pathogenesis of psoriasis brought to light approaches that proved successful in cancer treatment. Substantial advances in the emerging field of glycoconjugation highlight the rationale for the development of glucose-conjugated antipsoriatic drugs to increase their effectiveness, cellular selectivity, and tolerability. The presented approach offers a novel therapeutic strategy for the treatment of psoriasis and other hyperproliferative skin diseases.
📖 Papers frequently viewed together
1 Author (Sun Yu)
2 Citations
8 Citations
3 Citations
References95
Newest
#1Elise C. Kleyn (MAHSC: Manchester Academic Health Science Centre)H-Index: 1
#2Elaine Morsman (MAHSC: Manchester Academic Health Science Centre)H-Index: 1
Last. Lars Iversen (Aarhus University Hospital)H-Index: 67
view all 8 authors...
Chronic plaque psoriasis is a common, currently incurable, immune-mediated skin disease affecting approximately 2-3% of the population worldwide (1). Patients frequently require lifelong management...
9 CitationsSource
#1Adriana Rendon (Heidelberg University)H-Index: 1
#2Knut Schäkel (Heidelberg University)H-Index: 31
Research on psoriasis pathogenesis has largely increased knowledge on skin biology in general. In the past 15 years, breakthroughs in the understanding of the pathogenesis of psoriasis have been translated into targeted and highly effective therapies providing fundamental insights into the pathogenesis of chronic inflammatory diseases with a dominant IL-23/Th17 axis. This review discusses the mechanisms involved in the initiation and development of the disease, as well as the therapeutic options...
268 CitationsSource
#1Ailin Wang (Guangzhou University of Chinese Medicine)H-Index: 1
#2Jian-An Wei (Guangzhou University of Chinese Medicine)H-Index: 6
Last. Ling Han (Guangzhou University of Chinese Medicine)H-Index: 5
view all 10 authors...
Abstract Psoriasis is a chronic recurrent skin inflammatory disease, and inhibition of inflammation may be an effective means of treating psoriasis. The flavonoid genistein has a clear anti-inflammatory effect. However, the anti-psoriatic effects of genistein and their underlying mechanisms remain unclear. In this study, we investigated the effects of genistein on imiquimod (IMQ)-induced psoriasis-like skin lesions in vivo and explored the mechanisms underlying those effects in vitro. It was fou...
21 CitationsSource
#1Luísa Carvalho (NOVA: Universidade Nova de Lisboa)H-Index: 12
#2Ana Lourenço (NOVA: Universidade Nova de Lisboa)H-Index: 28
Last. Paula S. Branco (NOVA: Universidade Nova de Lisboa)H-Index: 29
view all 4 authors...
co-financed by the ERDF under the PT2020 Partnership Agreement (POCI-01-0145-FEDER-007265). The authors would like to thank Hovione FarmaCiencia SA for financial support.
5 CitationsSource
#1Zaina T. Al-Salama (Springer Science+Business Media)H-Index: 11
#2Lesley J. Scott (Springer Science+Business Media)H-Index: 63
Guselkumab (Tremfya®) is a human immunoglobulin G1 λ (IgG1λ) monoclonal antibody (mAb) that blocks the interleukin-23 (IL-23)-mediated signalling pathway and is the first in its class to be approved in adults with moderate to severe plaque psoriasis in several countries, including the USA and EU. In the VOYAGE trials, guselkumab was superior to placebo and to adalimumab at week 16 in terms of the proportion of patients achieving an Investigator Global Assessment (IGA) score of 0/1 and ≥ 90% impr...
16 CitationsSource
#1Isabel M. Haugh (Baylor University Medical Center)H-Index: 2
#2Allie K Preston (Texas A&M Health Science Center College of Medicine)H-Index: 1
Last. Alan Menter (Baylor University Medical Center)H-Index: 80
view all 4 authors...
: Risankizumab, a fully human IgG monoclonal antibody inhibitor of IL-23, is a therapeutic agent currently in late stage development for use in the treatment of moderate-to-severe plaque psoriasis. It is a biologic agent similar to guselkumab and tildrakizumab which targets IL-23 specifically, and has been primarily developed for use in moderate-to-severe psoriasis. USA-based pharmaceutical company Abbvie submitted it for a Biologics License Application to the US Food and Drug Administration (FD...
24 CitationsSource
#1Abeer A Hodeib (Tanta University)H-Index: 5
#2Yomna Mazid El-Hamd Neinaa (Tanta University)H-Index: 4
Last. Hanan AlSaeid Alshenawy (Tanta University)H-Index: 9
view all 4 authors...
BACKGROUND: Epidermal hyperproliferation with abnormal differentiation, inflammation, and angiogenesis are the key features of psoriasis. Glucose transporter-1 (GLUT-1) is a member of facilitative sugar transporters that are integral membrane glycoproteins moving sugar across cell membrane. OBJECTIVE: The objective of this study was to study the GLUT-1 expression in psoriasis. PATIENTS AND METHODS: Forty patients with psoriasis vulgaris and 20 healthy individuals were included in the study. Skin...
9 CitationsSource
1 CitationsSource
1 CitationsSource
#1Paul Hiebert (EPFL: École Polytechnique Fédérale de Lausanne)H-Index: 11
#2Sabine Werner (EPFL: École Polytechnique Fédérale de Lausanne)H-Index: 99
A crucial role for glucose metabolism has been identified in wound repair and in the pathogenesis of chronic inflammatory skin diseases, indicating that targeting metabolism is an approach for treating psoriasis.
7 CitationsSource
Cited By5
Newest
#2Sadiq UmarH-Index: 17
Last. Shiva ShahraraH-Index: 29
view all 8 authors...
Thirty percent of psoriasis patients develop psoriatic arthritis (PsA), nevertheless the mechanism remains unknown. Endogenous GU-rich miRNAs activate endosomal TLR7 that plays a critical role in autoimmune diseases. We found that endogenous TLR7 ligands, miR-29 and miR-Let7b, were markedly increased in PsA compared to osteoarthritis (OA) synovial fluid (SF)s. We showed that intradermal (i.d.) miR-Let7b injection promoted skin inflammation, which was characterized by amplified Th1 cells, CD68+ M...
2 CitationsSource
#1Marta Woźniak (Wrocław Medical University)H-Index: 8
Last. Siddarth Agrawal (Wrocław Medical University)H-Index: 6
view all 11 authors...
Methotrexate (MTX) is a commonly used antimetabolite, which inhibits folate and DNA synthesis to be effective in the treatment of various malignancies. However, MTX therapy is hindered by the lack of target tumor selectivity. We have designed, synthesized and evaluated a novel glucose–methotrexate conjugate (GLU–MTX) both in vitro and in vivo, in which a cleavable linkage allows intracellular MTX release after selective uptake through glucose transporter−1 (GLUT1). GLU–MTX inhibited the growth o...
3 CitationsSource
#2Jiaxin ZongH-Index: 1
Last. Mingmei ZhouH-Index: 6
view all 9 authors...
Pithecellobium clypearia Benth. (P. clypearia), a popular traditional Chinese medicine, has a significant anti-inflammatory efficacy. The crude water extract of the aerial part of P. clypearia has been clinically applied to treat upper respiratory tract infections, acute gastroenteritis, laryngitis and pharyngitis. However, the therapeutic mechanism of ethanol fraction of water extract (ESW) of P. clypearia to treat psoriasis should be complemented. The aim of our research was to clarify the pro...
Source
#1Doretta Cuffaro (UniPi: University of Pisa)H-Index: 5
#2Elisa Nuti (UniPi: University of Pisa)H-Index: 25
Last. Armando Rossello (UniPi: University of Pisa)H-Index: 28
view all 4 authors...
Matrix metalloproteinases (MMPs) and A disintegrin and Metalloproteinase (ADAMs) are zinc-dependent endopeptidases belonging to the metzincin superfamily. Upregulation of metzincin activity is a major feature in many serious pathologies such as cancer, inflammations, and infections. In the last decades, many classes of small molecules have been developed directed to inhibit these enzymes. The principal shortcomings that have hindered clinical development of metzincin inhibitors are low selectivi...
Source
#1Adrian Domiński (PAN: Polish Academy of Sciences)H-Index: 3
#2Monika Krawczyk (Silesian University of Technology)H-Index: 4
Last. Piotr Kurcok (PAN: Polish Academy of Sciences)H-Index: 24
view all 7 authors...
Abstract Biodegradable triblock copolymer poly(ethylene glycol)-b-polycarbonate-b-oligo([R]-3-hydroxybutyrate) was prepared via metal-free ring-opening polymerization of ketal protected six-membered cyclic carbonate followed by esterification with bacterial oligo([R]-3-hydroxybutyrate) (oPHB). Amphiphilic triblock copolymer self-organizes into micelles with a diameter of ∼25 nm. Acid-triggered hydrolysis of ketal groups to two hydroxyl groups causes an increase in hydrophilicity of the hydrophob...
3 CitationsSource